REGN Competitors & Alternatives
Compare Regeneron Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
REGN
Main Stock$781.49
Tradestie Score
50
Market Cap
$63.59B
P/E Ratio
20.0
Revenue Growth
0.2%
Analyst Upside
+8.7%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GILD
Gilead Sciences Inc
|
$143.72
|
$137.92B | - | 44 | Compare |
|
VRTX
Vertex Pharmaceuticals Inc
|
$515.44
|
$103.64B | 30.4 | 38 | Compare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$248.68
|
$60.38B | 45.1 | 43 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$984.39
|
$46.96B | 38.2 | 43 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$346.51
|
$36.81B | 62.9 | 48 | Compare |
|
INSM
Insmed, Inc.
|
$129.41
|
$31.13B | - | 54 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$96.73
|
$24.57B | - | 37 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$217.15
|
$22.61B | 37.5 | 47 | Compare |
|
GMAB
Genmab A/S ADS
|
$32.47
|
$19.56B | 26.2 | 41 | Compare |
|
INCY
Incyte Genomics Inc
|
$121.47
|
$16.93B | 16.1 | 50 | Compare |
More REGN Analysis
Data updated: Sep 12, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry